1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsResearch on Long COVID (part of the RECOVER Initiative) is sponsored by National Institutes of Health (NIH). The NIH RECOVER Initiative funds pathobiology studies to understand the biological mechanisms of Long COVID.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
RECOVER: Researching COVID to Enhance Recovery Long COVID is real. Millions of people who had COVID-19 still have symptoms lasting months or years. We created RECOVER to understand, diagnose, prevent, and treat Long COVID and help people who are suffering.
Millions of Americans suffer from Long COVID. This disease affects each person differently, so no single research study can provide all the answers to Long COVID for everyone. The National Institutes of Health (NIH) created the RECOVER Initiative to find answers across many different types of research studies.
RECOVER brings together clinicians, scientists, caregivers, patients, and community members to understand, diagnose, prevent, and treat Long COVID. We’ve created the world’s most comprehensive and diverse group of Long COVID study participants. We’re learning about Long COVID and testing different treatments.
We’re sharing our research, quickly learning from it, adapting, and constantly refocusing our efforts to ease suffering for millions of people. Together, we are working to understand, diagnose, prevent, and treat Long COVID.
Immune system may attack nervous system in some Long COVID patients RECOVER launches second phase of adult observational study RECOVER hub brings Long COVID research to rural, low-income communities Explore RECOVER’s progress and find out how to get involved: Each RECOVER research team can use all RECOVER findings, data, and biosamples (small amounts of blood, saliva, and tissue, also known as biospecimens) to inform and improve their study.
This way, we can learn more quickly about this complex condition and better understand, diagnose, prevent, and treat Long COVID. Researchers study drugs, medical devices, or other approaches that may help relieve Long COVID symptoms. Observational Cohort Studies Researchers study the health and symptoms of thousands of participants over several years.
No treatments or medicines are provided. Tissue Pathology (Autopsy) Studies Researchers study people who have died after having COVID, including people who did not have Long COVID. Researchers use RECOVER data and biosamples (biospecimens) to answer new and important questions about Long COVID.
Researchers study biosamples (biospecimens) from people with and without Long COVID to understand how COVID affects different body systems. Electronic Health Records (EHR) Studies Researchers study millions of digital medical records, called EHRs, to understand changes over time, learn who may have Long COVID, and learn how to treat or prevent it.
Each RECOVER research team can use all RECOVER findings, data, and biosamples (small amounts of blood, saliva, and tissue, also known as biospecimens) to inform and improve their study. This way, we can learn more quickly about this complex condition and better understand, diagnose, prevent, and treat Long COVID. Researchers study drugs, medical devices, or other approaches that may help relieve Long COVID symptoms.
Observational Cohort Studies Researchers study the health and symptoms of thousands of participants over several years. No treatments or medicines are provided. Tissue Pathology (Autopsy) Studies Researchers study people who have died after having COVID, including people who did not have Long COVID.
Researchers use RECOVER data and biosamples (biospecimens) to answer new and important questions about Long COVID. Researchers study biosamples (biospecimens) from people with and without Long COVID to understand how COVID affects different body systems.
Electronic Health Records (EHR) Studies Researchers study millions of digital medical records, called EHRs, to understand changes over time, learn who may have Long COVID, and learn how to treat or prevent it. RECOVER shares the data between the different types of research to understand, diagnose, prevent, and treat Long COVID.
Observational Cohort Studies Explore the study overview RECOVER-Treating Long COVID (RECOVER-TLC) is now enrolling participants in the next phase of RECOVER clinical trials. The REVERSE-LC study will test the safety and effectiveness of the drug barcitinib to help improve thinking and memory problems and reduce fatigue. Share ideas for Long COVID treatment RECOVER-TLC is accepting possible treatment ideas for symptoms of Long COVID.
To date, more than 550 drugs, medical devices, and other therapies have been submitted, and 4 treatment ideas have been selected for the first round of RECOVER-TLC trials. Patients, caregivers, healthcare providers, researchers, and others can continue submitting ideas through the RECOVER-TLC Intervention Information Request Form. Explore COVID-19 Resources View the latest statistics about COVID-19 cases in the United States.
NIH Community Engagement Alliance Find information to help reach communities hit hardest by the pandemic. Clinical Overview of Long Find information to help treat patients. Encuentre recursos en español, sobre el COVID-19.
According to the current listing, eligibility includes: Investigators from various groups, including those with previously funded RECOVER pathobiology studies. Confirm the full requirements in the official notice before applying.
The current listing shows proposed budgets generally not to exceed $800,000 per year, total direct costs not to exceed $500,000 per year. Verify award ceilings, matching requirements, and allowable costs in the official notice.
Research on Long COVID (part of the RECOVER Initiative) is funded by National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article